Overview

Continuous Endostar Infusion Combined With Radiotherapy in Esophageal Cancer Patients

Status:
Unknown status
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
This study is to explore the clinical efficacy of continuous Endostar infusion combined with radiotherapy in esophageal cancer patients.
Phase:
Phase 2
Details
Lead Sponsor:
Jiangsu Simcere Pharmaceutical Co., Ltd.
Collaborator:
The First People's Hospital of Lianyungang
Treatments:
Endostar protein